Thymosin market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to accelerate the growth of the market include Ongoing research and clinical trial and their results associated with the application of thymosin in many medical conditions, and the growing burden of Hepatitis A virus (HAV) and hepatitis B virus (HBV) across the globe. Thymosin is the hormone secreted by the thalamus and its primary function is to stimulate the production of T-cells that are an important part of the immune system. Additionally, it assists to develop B-cells into plasma cells to produce antibodies. Thymosin (thymalfasin) is indicated as monotherapy or combination therapy with interferon for the treatment of chronic hepatitis B and C.
In addition, growing R&D activities regarding thymosin and clinical trials for thymosin are fuelling the growth of the market. Many pharmaceutical and biotechnological companies are investing in clinical trials and drug development activities of thymosin, which is further escalating the market. The government initiatives and funding for new drug development is also expected to support the R&D in thymosin. Furthermore, the increasing number of patients with colorectal cancer and the ability of thymosin to cure such type of cancer is augmenting the growth of the market. Thymosin is indicated as adjuvant therapy for chemotherapy-induced immune depression, immune suppression and immune insufficiency in patients with non-small cell lung carcinoma (NSCLC). Additionally, it is used in colorectal cancer, head and neck cancer, leukaemia’s, pancreatic carcinoma, renal cell carcinoma, malignant melanoma, hepatocellular carcinoma (HCC), breast cancer and non-Hodgkin’s lymphoma (CHOP program). These factors are contributing towards driving the growth of the global thymosin market.
To Request a Sample of our Report on Thymosin Market: https://www.omrglobal.com/request-sample/thymosin-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: F.Hoffman La-Roche AG, Merck KGaA, and Gilead Sciences, Inc., among others.
Thymosin Market Report Segmentation
By Type
- Thymosin Alpha-1
- Thymosin Alpha-2,
- Thymosin Beta-4
By Application
- Emphysema
- Motor Neurone Disease
- Malnutrition
- Diabetes
- Infection
- Cancer
- Hair Loss
- Wound Healing
- Other
A full Report of Thymosin Market is Available @ https://www.omrglobal.com/industry-reports/thymosin-market
Thymosin Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/thymosin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
